sentence_id,words,labels,pos_tag
0,These,B,DT
0,patients,I,NNS
0,are,O,VBP
0,more,B,RBR
0,likely,I,JJ
0,to,O,TO
0,test,B,VB
0,positive,I,JJ
0,for,I,IN
0,viral,I,JJ
0,RNA,I,NNP
0,in,I,IN
0,stool,I,NN
0,",",O,","
0,to,O,TO
0,have,B,VB
0,a,I,DT
0,longer,B,RBR
0,delay,I,NN
0,before,I,IN
0,viral,I,JJ
0,clearance,I,NN
0,",",O,","
0,and,O,CC
0,to,O,TO
0,experience,B,VB
0,delayed,I,JJ
0,diagnosis,I,NN
0,compared,O,VBN
0,with,O,IN
0,patients,B,NNS
0,with,I,IN
0,only,I,JJ
0,respiratory,I,NN
0,symptoms,I,NNS
0,.,O,.
1,Top,B,JJ
1,-,I,:
1,down,I,RP
1,cleaning,I,VBG
1,adequate,B,JJ
1,to,O,TO
1,reduce,B,VB
1,bioburden,B,NN
1,.,O,.
2,To,O,TO
2,reduce,B,VB
2,the,B,DT
2,use,I,NN
2,of,I,IN
2,surgical,I,JJ
2,masks,I,NNS
2,and,O,CC
2,to,O,TO
2,reduce,B,VB
2,potential,B,JJ
2,COVID-19,I,NNP
2,exposure,I,NN
2,",",O,","
2,use,B,VBP
2,relatively,I,RB
2,long,I,JJ
2,(,I,(
2,eg,I,NN
2,",",I,","
2,12hours,I,CD
2,),I,)
2,staff,I,NN
2,shifts,I,NNS
2,.,O,.
3,Children,B,NNP
3,under,I,IN
3,10,I,CD
3,years,I,NNS
3,of,I,IN
3,age,I,NN
3,were,O,VBD
3,less,B,RBR
3,likely,I,JJ
3,to,O,TO
3,receive,B,VB
3,a,I,DT
3,positive,I,JJ
3,result,I,NN
3,than,O,IN
3,were,O,VBD
3,persons,B,NNS
3,10,I,CD
3,years,I,NNS
3,of,I,IN
3,age,I,NN
3,or,I,CC
3,older,I,JJR
4,During,B,IN
4,a,I,DT
4,two,I,CD
4,week,I,NN
4,period,I,NN
4,in,I,IN
4,February,I,NNP
4,2020,I,CD
4,",",O,","
4,the,B,DT
4,emotional,I,JJ
4,state,I,NN
4,and,O,CC
4,behavior,B,NN
4,of,I,IN
4,participants,I,NNS
4,in,B,IN
4,Hubei,I,NNP
4,improved,B,VBD
4,",",O,","
4,but,O,CC
4,the,B,DT
4,quality,I,NN
4,of,I,IN
4,sleep,I,NN
4,did,O,VBD
4,not,O,RB
4,.,O,.
5,During,B,IN
5,a,I,DT
5,two,I,CD
5,-,I,:
5,week,I,NN
5,period,I,NN
5,",",O,","
5,front,B,JJ
5,-,I,:
5,line,I,NN
5,health,I,NN
5,workers,I,NNS
5,and,O,CC
5,people,B,NNS
5,in,I,IN
5,Hubei,I,NNP
5,Province,I,NNP
5,became,O,VBD
5,less,B,RBR
5,anxious,B,JJ
5,about,I,IN
5,the,I,DT
5,COVID-19,I,NNP
5,epidemic,I,NN
5,",",O,","
5,but,O,CC
5,sleep,B,JJ
5,quality,I,NN
5,did,O,VBD
5,not,B,RB
5,improve,B,VB
5,.,O,.
6,We,O,PRP
6,report,B,VBP
6,that,O,IN
6,the,B,DT
6,nano,I,JJ
6,-,I,:
6,dimension,I,NN
6,sign+,B,NN
6,with,I,IN
6,the,B,DT
6,film,I,NN
6,thickness,I,NN
6,",",O,","
6,ranging,O,VBG
6,from,O,IN
6,17–42,O,CD
6,nm,O,NNS
6,.,O,.
7,The,O,DT
7,question,B,NN
7,is,O,VBZ
7,if,O,IN
7,the,B,DT
7,nano,I,NN
7,-,I,:
7,dimension,I,NN
7,also,O,RB
7,sign+,B,VBZ
7,with,I,IN
7,columnar,B,JJ
7,crystal,I,JJ
7,size,I,NN
7,.,O,.
8,Our,B,PRP$
8,patient,I,NN
8,improved,B,VBN
8,significantly,B,RB
8,.,O,.
9,We,O,PRP
9,sought,O,VBD
9,to,O,TO
9,show,B,VB
9,how,O,WRB
9,these,B,DT
9,control,I,VB
9,measures,I,NNS
9,impacted,B,VBN
9,the,B,DT
9,containment,I,NN
9,of,I,IN
9,the,I,DT
9,epidemic,I,NN
9,.,O,.
10,This,B,DT
10,study,I,NN
10,aims,O,VBZ
10,to,O,TO
10,investigate,B,VB
10,whether,B,IN
10,MSC,B,NNP
10,transplantation,I,NN
10,improves,B,VBZ
10,the,B,DT
10,outcome,I,NN
10,of,I,IN
10,7,I,CD
10,enrolled,I,JJ
10,patients,I,NNS
10,with,I,IN
10,COVID-19,I,NNP
10,pneumonia,I,NN
10,in,B,IN
10,Beijing,I,NNP
10,YouAn,I,NNP
10,Hospital,I,NNP
10,",",I,","
10,China,I,NNP
10,",",O,","
10,from,B,IN
10,Jan,I,NNP
10,23,I,CD
10,",",I,","
10,2020,I,CD
10,to,I,TO
10,Feb,I,NNP
10,16,I,CD
10,",",I,","
10,2020,I,CD
10,.,O,.
11,MSCs,B,NNP
11,could,B,MD
11,cure,B,VB
11,or,O,CC
11,significantly,B,RB
11,improve,B,VB
11,the,B,DT
11,functional,I,JJ
11,outcomes,I,NNS
11,of,I,IN
11,seven,I,CD
11,patients,I,NNS
11,without,B,IN
11,observed,I,JJ
11,adverse,I,JJ
11,effects,I,NNS
11,.,O,.
12,In,O,IN
12,light,O,NN
12,of,O,IN
12,this,O,DT
12,",",O,","
12,a,O,DT
12,countermeasure,O,NN
12,that,O,WDT
12,has,O,VBZ
12,been,O,VBN
12,shown,B,VBN
12,to,O,TO
12,be,O,VB
12,effective,B,JJ
12,in,I,IN
12,the,B,DT
12,analogous,I,JJ
12,condition,I,NN
12,of,I,IN
12,HAPE,I,NNP
12,is,O,VBZ
12,Acetazolamide,B,NNP
12,.,O,.
13,In,B,IN
13,children,I,NNS
13,COVID-19,B,NNP
13,related,I,JJ
13,disease,I,NN
13,is,O,VBZ
13,less,B,RBR
13,frequent,I,JJ
13,and,O,CC
13,less,B,RBR
13,aggressive,I,JJ
13,.,O,.
14,On,O,IN
14,the,O,DT
14,basis,O,NN
14,of,O,IN
14,current,B,JJ
14,studies,I,NNS
14,",",O,","
14,it,O,PRP
14,would,O,MD
14,appear,O,VB
14,that,O,IN
14,the,B,DT
14,combined,I,JJ
14,antiviral,I,JJ
14,treatment,I,NN
14,has,O,VBZ
14,shown,O,VBN
14,the,O,DT
14,highest,B,JJS
14,success,B,NN
14,rate,I,NN
14,.,O,.
15,A,B,DT
15,five,I,CD
15,-,I,:
15,day,I,NN
15,delay,I,NN
15,in,I,IN
15,implementation,I,NN
15,would,B,MD
15,have,O,VB
15,increased,B,VBN
15,epidemic,B,JJ
15,size,I,NN
15,in,B,IN
15,mainland,I,NN
15,China,I,NNP
15,three,B,CD
15,-,I,:
15,fold,I,NN
15,.,O,.
16,In,O,IN
16,the,B,DT
16,"""",I,NN
16,Severe,I,NNP
16,"""",I,NNP
16,group,I,NN
16,",",O,","
16,there,O,EX
16,was,O,VBD
16,significantly,B,RB
16,more,B,JJR
16,elderly,B,JJ
16,patients,I,NNS
16,(,O,(
16,p=0.045,O,NN
16,),O,)
16,",",O,","
16,higher,B,JJR
16,lactate,B,JJ
16,dehydrogenase,I,NN
16,levels,I,NNS
16,(,O,(
16,p=0.002,O,NN
16,),O,)
16,",",O,","
16,and,O,CC
16,elevated,B,VBD
16,C,B,NNP
16,-,I,:
16,Reactive,I,JJ
16,protein,I,NN
16,levels,I,NNS
16,compared,O,VBN
16,to,O,TO
16,the,B,DT
16,"""",I,NNP
16,Mild,I,NNP
16,to,I,TO
16,Moderate,I,NNP
16,"""",I,NNP
16,group,I,NN
16,(,O,(
16,p<0.001,O,NN
16,),O,)
16,.,O,.
17,There,O,EX
17,is,O,VBZ
17,clear,B,JJ
17,evidence,I,NN
17,that,O,IN
17,IL-6,B,NNP
17,peak,I,NN
17,levels,I,NNS
17,are,O,VBP
17,associated,B,VBN
17,with,I,IN
17,severity,B,NN
17,of,I,IN
17,pulmonary,I,JJ
17,complications,I,NNS
17,.,O,.
18,Tweets,B,NNS
18,from,I,IN
18,unverified,I,JJ
18,Twitter,I,NNP
18,accounts,I,NNS
18,contained,B,VBD
18,more,B,JJR
18,misinformation,I,NN
18,(,O,(
18,31.0,O,CD
18,%,O,NN
18,vs,O,JJ
18,12.6,O,CD
18,%,O,NN
18,for,O,IN
18,verified,O,JJ
18,accounts,O,NNS
18,",",O,","
18,p,O,NN
18,:,O,:
18,<,O,JJ
18,0.001,O,CD
18,),O,)
18,.,O,.
19,Preliminary,B,JJ
19,evidence,I,NN
19,suggests,B,VBZ
19,children,B,NNS
19,are,O,VBP
19,just,B,RB
19,as,I,RB
19,likely,I,JJ
19,as,O,IN
19,adults,B,NNS
19,to,O,TO
19,become,B,VB
19,infected,I,JJ
19,with,I,IN
19,SARS,I,NNP
19,-,I,:
19,CoV-2,I,JJ
19,but,O,CC
19,are,O,VBP
19,less,B,RBR
19,likely,I,JJ
19,to,O,TO
19,be,B,VB
19,symptomatic,I,JJ
19,or,O,CC
19,develop,B,VB
19,severe,I,JJ
19,symptoms,I,NNS
19,.,O,.
20,Children,B,NNP
20,more,B,RBR
20,often,I,RB
20,have,B,VBP
20,gastrointestinal,I,JJ
20,symptoms,I,NNS
20,compared,O,VBN
20,with,O,IN
20,adults,B,NNS
20,.,O,.
21,In,O,IN
21,contrast,O,NN
21,",",O,","
21,adults,B,NNS
21,more,B,RBR
21,often,I,RB
21,have,B,VBP
21,a,I,DT
21,nosocomial,I,JJ
21,exposure,I,NN
21,.,O,.
22,In,O,IN
22,this,B,DT
22,paper,I,NN
22,",",O,","
22,we,O,PRP
22,describe,B,VBP
22,the,O,DT
22,potential,B,NN
22,of,O,IN
22,simulation,B,NN
22,to,O,TO
22,improve,B,VB
22,hospital,B,NN
22,responses,I,NNS
22,to,I,TO
22,the,I,DT
22,COVID-19,I,NNP
22,crisis,I,NN
22,.,O,.
23,On,B,IN
23,day,I,NN
23,10,I,CD
23,",",O,","
23,her,B,PRP$
23,chest,I,NN
23,radiography,I,NN
23,and,O,CC
23,lung,B,NN
23,compliance,I,NN
23,improved,B,VBD
23,.,O,.
24,During,B,IN
24,the,I,DT
24,first,I,JJ
24,22,I,CD
24,days,I,NNS
24,",",O,","
24,the,B,DT
24,incidence,I,NN
24,rate,I,NN
24,of,I,IN
24,COVID-19,I,NNP
24,increased,B,VBD
24,significantly,B,RB
24,to,B,TO
24,reach,I,VB
24,1.81,I,CD
24,cases,I,NNS
24,per,I,IN
24,million,I,CD
24,persons,I,NNS
24,(,O,(
24,p<0.001,O,NN
24,),O,)
24,.,O,.
25,Development,B,NNP
25,of,I,IN
25,new,I,JJ
25,onset,I,VBN
25,myocardial,I,JJ
25,injury,I,NN
25,during,B,IN
25,COVID-19,I,NNP
25,also,O,RB
25,sign+,B,VBZ
25,mortality,B,NN
25,.,O,.
26,Participants,O,NNS
26,with,O,IN
26,better,B,JJR
26,sleep,B,NN
26,quality,I,NN
26,or,O,CC
26,less,B,JJR
26,frequency,B,NN
26,of,I,IN
26,early,I,JJ
26,awakenings,I,NNS
26,reported,B,VBD
26,lower,B,JJR
26,PTSS,B,NNP
26,.,O,.
27,Conclusion,O,NN
27,Optimising,B,VBG
27,our,I,PRP$
27,procedures,I,NNS
27,reduces,B,VBZ
27,anxiety,B,NN
27,and,O,CC
27,reassures,O,VBZ
27,the,O,DT
27,population,O,NN
27,and,O,CC
27,decision,O,NN
27,makers,O,NNS
27,.,O,.
28,For,B,IN
28,an,I,DT
28,epidemic,I,JJ
28,to,I,TO
28,take,I,VB
28,hold,I,NN
28,",",O,","
28,the,B,DT
28,value,I,NN
28,of,I,IN
28,R0,I,NNP
28,must,B,MD
28,be,O,VB
28,greater,B,JJR
28,than,I,IN
28,unity,B,NN
28,in,O,IN
28,value,B,NN
28,.,O,.
29,Results,O,NNS
29,Respiratory,B,NNP
29,illness,I,NN
29,is,O,VBZ
29,the,O,DT
29,dominant,B,JJ
29,clinical,B,JJ
29,manifestation,B,NN
29,of,I,IN
29,COVID-19,B,NNP
29,;,O,:
29,CV,B,NNP
29,involvement,I,NN
29,occurs,B,VBZ
29,much,I,RB
29,less,I,JJR
29,commonly,I,RB
29,.,O,.
30,This,B,DT
30,indicates,B,VBZ
30,that,O,IN
30,predictions,B,NNS
30,using,I,VBG
30,more,I,RBR
30,complex,I,JJ
30,models,I,NNS
30,may,B,MD
30,not,B,RB
30,be,O,VB
30,more,B,RBR
30,reliable,B,JJ
30,compared,O,VBN
30,to,O,TO
30,using,B,VBG
30,a,I,DT
30,simpler,I,NN
30,model,I,NN
30,.,O,.
31,Emerging,B,VBG
31,data,I,NNS
31,suggest,B,VBP
31,an,O,DT
31,increased,B,VBN
31,association,B,NN
31,and,O,CC
31,a,O,DT
31,heightened,B,JJ
31,mortality,B,NN
31,in,O,IN
31,patients,B,NNS
31,of,I,IN
31,COVID-19,I,NNP
31,with,I,IN
31,comorbidities,I,NNS
31,.,O,.
32,Taken,O,VBN
32,together,O,RB
32,",",O,","
32,these,B,DT
32,data,I,NNS
32,seem,B,VBP
32,to,I,TO
32,indicate,I,VB
32,that,O,IN
32,there,O,EX
32,might,B,MD
32,be,O,VB
32,a,O,DT
32,sex,B,NN
32,predisposition,B,NN
32,to,O,TO
32,COVID-19,B,NNP
32,",",O,","
32,with,O,IN
32,men,B,NNS
32,more,B,RBR
32,prone,B,NN
32,to,I,TO
32,being,I,VBG
32,affected,I,VBN
32,.,O,.
33,Measurements,O,NNS
33,and,O,CC
33,Main,O,NNP
33,Results,O,NNP
33,Cross,B,NNP
33,-,I,:
33,infection,I,NN
33,in,B,IN
33,the,I,DT
33,operating,I,NN
33,rooms,I,NNS
33,of,I,IN
33,the,I,DT
33,4,I,CD
33,hospitals,I,NNS
33,was,O,VBD
33,effectively,B,RB
33,reduced,B,VBN
33,by,O,IN
33,implementing,B,VBG
33,the,I,DT
33,new,I,JJ
33,measures,I,NNS
33,and,I,CC
33,procedures,I,NNS
33,.,O,.
34,Compared,O,VBN
34,with,O,IN
34,the,B,DT
34,blood,I,NN
34,test,I,NN
34,at,I,IN
34,disease,I,NN
34,onset,I,NN
34,",",O,","
34,the,B,DT
34,results,I,NNS
34,showed,B,VBD
34,that,O,IN
34,the,B,DT
34,eosinophil,I,NN
34,count,I,NN
34,was,O,VBD
34,still,B,RB
34,below,B,IN
34,the,B,DT
34,normal,I,JJ
34,range,I,NN
34,",",O,","
34,which,O,WDT
34,was,O,VBD
34,even,B,RB
34,lower,B,JJR
34,than,O,IN
34,the,B,DT
34,first,I,JJ
34,time,I,NN
34,.,O,.
35,The,O,DT
35,spectrum,O,NN
35,of,O,IN
35,chest,O,NN
35,imaging,O,VBG
35,manifestations,B,NNS
35,of,I,IN
35,COVID-19,B,NNP
35,pneumonia,I,NN
35,upon,B,IN
35,admission,I,NN
35,includes,O,VBZ
35,B,B,NNP
35,-,I,:
35,lines,I,NNS
35,and,I,CC
35,consolidations,I,NNS
35,on,I,IN
35,US,I,NNP
35,",",O,","
35,consolidations,B,NNS
35,and,I,CC
35,hazy,I,NN
35,increased,I,VBD
35,opacities,I,NNS
35,on,I,IN
35,CXR,I,NNP
35,",",O,","
35,and,O,CC
35,multifocal,B,JJ
35,GGO,I,NNP
35,with,I,IN
35,consolidations,I,NNS
35,on,I,IN
35,CT,I,NNP
35,.,O,.
36,Collectively,O,RB
36,",",O,","
36,these,B,DT
36,results,I,NNS
36,suggest,B,VBP
36,that,O,IN
36,MSCs,B,NNP
36,significantly,B,RB
36,improve,B,VB
36,the,B,DT
36,survival,I,NN
36,rate,I,NN
36,of,I,IN
36,H7N9-induced,I,NNP
36,ARDS,I,NNP
36,and,O,CC
36,provide,O,VB
36,a,O,DT
36,theoretical,O,JJ
36,basis,O,NN
36,for,O,IN
36,the,B,DT
36,treatment,I,NN
36,of,I,IN
36,H7N9-induced,I,NNP
36,ARDS,I,NNP
36,in,O,IN
36,both,O,DT
36,preclinical,O,JJ
36,research,O,NN
36,and,O,CC
36,clinical,O,JJ
36,studies,O,NNS
36,.,O,.
37,In,O,IN
37,our,B,PRP$
37,study,I,NN
37,",",O,","
37,we,O,PRP
37,demonstrate,B,VBP
37,that,O,DT
37,nonidentifiability,B,NN
37,in,I,IN
37,model,I,NN
37,calibrations,I,NNS
37,using,I,VBG
37,the,I,DT
37,confirmed,I,VBN
37,-,I,:
37,case,I,NN
37,data,I,NNS
37,is,O,VBZ
37,the,O,DT
37,main,B,JJ
37,reason,B,NN
37,for,I,IN
37,such,B,JJ
37,wide,I,JJ
37,variations,I,NNS
37,.,O,.
38,Numerical,B,JJ
38,simulations,I,NNS
38,show,B,VBP
38,the,O,DT
38,suitability,B,NN
38,of,O,IN
38,the,B,DT
38,proposed,I,VBN
38,COVID-19,I,NNP
38,model,I,NN
38,for,O,IN
38,the,B,DT
38,outbreak,I,NN
38,that,O,WDT
38,occurred,O,VBD
38,in,B,IN
38,Wuhan,I,NNP
38,",",I,","
38,China,I,NNP
38,.,O,.
39,The,B,DT
39,number,I,NN
39,of,I,IN
39,T,I,NNP
39,cells,I,NNS
39,significantly,B,RB
39,decreased,B,VBN
39,",",O,","
39,and,O,CC
39,more,B,JJR
39,hampered,B,VBN
39,in,O,IN
39,severe,B,JJ
39,cases,I,NNS
39,.,O,.
40,China,B,NNP
40,’s,I,NNP
40,bond,I,NN
40,and,O,CC
40,strict,B,JJ
40,containment,I,NN
40,measures,I,NNS
40,have,O,VBP
40,been,O,VBN
40,proved,B,VBN
40,(,O,(
40,in,B,IN
40,practice,I,NN
40,),O,)
40,to,O,TO
40,significantly,B,RB
40,reduce,B,VB
40,the,B,DT
40,spread,I,NN
40,of,I,IN
40,the,I,DT
40,epidemic,I,NN
40,.,O,.
41,Patients,B,NNS
41,with,I,IN
41,COVID-19,I,NNP
41,also,O,RB
41,have,O,VBP
41,lower,B,JJR
41,level,B,NN
41,of,I,IN
41,regulatory,I,JJ
41,T,I,NNP
41,cells,I,NNS
41,",",O,","
41,and,O,CC
41,more,B,JJR
41,obviously,I,RB
41,damaged,B,VBN
41,in,B,IN
41,severe,I,JJ
41,cases,I,NNS
41,.,O,.
42,Most,B,JJS
42,of,I,IN
42,severe,I,JJ
42,cases,I,NNS
42,demonstrated,B,VBD
42,elevated,B,JJ
42,levels,B,NNS
42,of,I,IN
42,infection,I,NN
42,-,I,:
42,related,I,JJ
42,biomarkers,I,NNS
42,and,O,CC
42,inflammatory,B,JJ
42,cytokines,I,NNS
42,.,O,.
43,We,O,PRP
43,found,B,VBD
43,that,O,IN
43,the,B,DT
43,epidemic,I,NN
43,of,I,IN
43,China,I,NNP
43,should,B,MD
43,peak,B,VB
43,by,B,IN
43,late,I,JJ
43,February,I,NNP
43,",",O,","
43,showing,O,VBG
43,gradual,B,JJ
43,decline,B,NN
43,by,B,IN
43,end,I,NN
43,of,I,IN
43,April,I,NNP
43,.,O,.
44,Older,B,JJR
44,age,B,NN
44,and,O,CC
44,co,B,NN
44,-,I,:
44,morbid,I,NN
44,conditions,I,NNS
44,increase,B,VBP
44,the,B,DT
44,fatality,I,NN
44,.,O,.
45,Using,O,VBG
45,the,O,DT
45,Akaike,B,NNP
45,Information,I,NNP
45,Criterion,I,NNP
45,(,I,(
45,AIC,I,NNP
45,),I,)
45,for,I,IN
45,model,I,NN
45,selection,I,NN
45,",",O,","
45,we,O,PRP
45,show,B,VBP
45,that,O,IN
45,an,B,DT
45,SIR,I,NNP
45,model,I,NN
45,performs,O,NNS
45,much,B,RB
45,better,B,JJR
45,than,O,IN
45,an,B,DT
45,SEIR,I,NNP
45,model,I,NN
45,in,O,IN
45,representing,B,VBG
45,the,I,DT
45,information,I,NN
45,contained,I,VBN
45,in,I,IN
45,the,I,DT
45,confirmed,I,JJ
45,-,I,:
45,case,I,NN
45,data,I,NNS
45,.,O,.
46,As,O,IN
46,the,B,DT
46,severity,I,NN
46,of,I,IN
46,the,I,DT
46,disease,I,NN
46,increased,B,VBD
46,",",O,","
46,digestive,B,JJ
46,symptoms,I,NNS
46,became,I,VBD
46,more,B,RBR
46,pronounced,I,JJ
46,.,O,.
47,This,B,DT
47,evidence,I,NN
47,supports,B,VBZ
47,the,O,DT
47,benefit,B,NN
47,of,O,IN
47,using,B,VBG
47,ACEIs,I,NNP
47,or,O,CC
47,ARBs,B,NNP
47,to,O,TO
47,potentially,B,RB
47,contribute,B,VB
47,to,I,TO
47,the,O,DT
47,improvement,B,NN
47,of,O,IN
47,clinical,B,JJ
47,outcomes,I,NNS
47,of,I,IN
47,COVID-19,I,JJ
47,patients,I,NNS
47,with,B,IN
47,hypertension,I,NN
47,.,O,.
48,Both,O,DT
48,epidemiological,B,JJ
48,and,I,CC
48,laboratory,I,JJ
48,studies,I,NNS
48,have,O,VBP
48,shown,B,VBN
48,that,O,IN
48,ambient,B,JJ
48,temperature,I,NN
48,could,B,MD
48,affect,B,VB
48,the,B,DT
48,transmission,I,NN
48,and,O,CC
48,survival,B,NN
48,of,I,IN
48,coronaviruses,I,NNS
48,.,O,.
49,A,B,DT
49,trial,I,NN
49,of,I,IN
49,2,I,CD
49,g,I,NN
49,of,I,IN
49,PO,I,NNP
49,or,O,CC
49,IV,B,NNP
49,glutathione,I,NN
49,was,O,VBD
49,used,O,VBN
49,in,B,IN
49,both,I,DT
49,patients,I,NNS
49,and,O,CC
49,improved,B,VBN
49,their,B,PRP$
49,dyspnea,I,NN
49,within,B,IN
49,1,I,CD
49,h,I,NN
49,of,I,IN
49,use,I,NN
49,.,O,.
50,Recent,B,JJ
50,outbreak,I,NN
50,of,I,IN
50,Coronavirus,I,NNP
50,disease,I,NN
50,(,O,(
50,COVID-19,B,NNP
50,),O,)
50,pandemic,O,VBP
50,around,B,IN
50,the,I,DT
50,world,I,NN
50,is,O,VBZ
50,associated,B,VBN
50,with,I,IN
50,‘,O,NNP
50,severe,B,JJ
50,acute,I,JJ
50,respiratory,I,NN
50,syndrome,I,NN
50,’,O,NNP
50,(,O,(
50,SARS,B,NNP
50,-,I,:
50,CoV2,I,NN
50,),O,)
50,in,B,IN
50,humans,I,NNS
50,.,O,.
51,This,B,DT
51,study,I,NN
51,demonstrated,B,VBD
51,that,O,IN
51,intravenous,B,JJ
51,infusion,I,NN
51,of,I,IN
51,MSCs,I,NNP
51,is,O,VBZ
51,a,O,DT
51,safe,B,JJ
51,and,O,CC
51,effective,B,JJ
51,approach,O,NN
51,for,O,IN
51,treating,B,VBG
51,patients,B,NNS
51,with,I,IN
51,COVID-19,I,NNP
51,pneumonia,I,NN
51,",",O,","
51,including,O,VBG
51,elderly,B,JJ
51,patients,I,NNS
51,displaying,I,VBG
51,severe,I,JJ
51,pneumonia,I,NN
51,.,O,.
52,Abstract,O,VB
52,The,B,DT
52,confirmed,I,NN
52,and,I,CC
52,suspected,I,JJ
52,cases,I,NNS
52,of,I,IN
52,the,I,DT
52,2019,I,CD
52,novel,I,NN
52,coronavirus,I,NN
52,disease,I,NN
52,(,O,(
52,COVID-19,B,NNP
52,),O,)
52,have,O,VBP
52,increased,B,VBN
52,not,O,RB
52,only,O,RB
52,in,B,IN
52,Wuhan,I,NNP
52,",",I,","
52,Hubei,I,NNP
52,Province,I,NNP
52,but,O,CC
52,also,O,RB
52,China,B,NNP
52,and,O,CC
52,the,B,DT
52,world,I,NN
52,.,O,.
53,When,B,WRB
53,mean,I,JJ
53,temperature,I,NN
53,(,I,(
53,lag0–14,I,NN
53,),I,)
53,was,I,VBD
53,below,I,IN
53,3,I,CD
53,°,I,JJ
53,C,I,NNP
53,",",O,","
53,each,B,DT
53,1,I,CD
53,°,I,NN
53,C,I,NNP
53,rise,I,NN
53,was,O,VBD
53,associated,B,VBN
53,with,I,IN
53,a,O,DT
53,4.861,B,CD
53,%,I,NN
53,(,O,(
53,95,O,CD
53,%,O,NN
53,CI,O,NNP
53,:,O,:
53,3.209–6.513,O,CD
53,),O,)
53,increase,B,NN
53,in,I,IN
53,the,B,DT
53,daily,I,JJ
53,number,I,NN
53,of,I,IN
53,COVID-19,I,NNP
53,confirmed,I,JJ
53,cases,I,NNS
53,.,O,.
54,In,O,IN
54,multiple,B,JJ
54,logistic,I,JJ
54,regression,I,NN
54,analyses,I,NNS
54,",",O,","
54,the,B,DT
54,COVID-19,I,NNP
54,knowledge,I,NN
54,score,I,NN
54,(,O,(
54,OR,O,NNP
54,:,O,:
54,0.75,O,CD
54,-,O,:
54,0.90,O,CD
54,",",O,","
54,P<0.001,O,NNP
54,),O,)
54,was,O,VBD
54,significantly,B,RB
54,associated,B,VBN
54,with,I,IN
54,a,O,DT
54,lower,B,JJR
54,likelihood,B,NN
54,of,I,IN
54,negative,I,JJ
54,attitudes,I,NNS
54,and,O,CC
54,preventive,B,JJ
54,practices,I,NNS
54,towards,I,IN
54,COVID-2019,I,NNP
54,.,O,.
55,This,B,DT
55,reflections,I,NNS
55,article,I,NN
55,provides,B,VBZ
55,insight,I,JJ
55,toward,I,IN
55,nursing,B,VBG
55,innovations,I,NNS
55,to,O,TO
55,reduce,B,VB
55,the,B,DT
55,overuse,I,NN
55,of,I,IN
55,personal,I,JJ
55,protective,I,JJ
55,equipment,I,NN
55,while,B,IN
55,maintaining,I,VBG
55,a,I,DT
55,safe,I,JJ
55,environment,I,NN
55,for,B,IN
55,staff,I,NN
55,taking,I,VBG
55,care,I,NN
55,of,I,IN
55,COVID-19,I,NNP
55,patients,I,NNS
55,.,O,.
56,Although,O,IN
56,the,B,DT
56,emerging,I,VBG
56,data,I,NNS
56,hints,B,NNS
56,to,I,TO
56,an,O,DT
56,increase,B,NN
56,in,I,IN
56,mortality,B,NN
56,in,B,IN
56,COVID-19,I,NNP
56,patients,I,NNS
56,with,O,IN
56,known,O,JJ
56,hypertension,B,NN
56,",",O,","
56,diabetes,B,NNS
56,and,O,CC
56,CVD,B,NNP
56,",",O,","
56,it,O,PRP
56,should,O,MD
56,be,O,VB
56,noted,O,VBN
56,that,O,IN
56,it,O,PRP
56,was,O,VBD
56,not,B,RB
56,adjusted,I,VBN
56,for,I,IN
56,multiple,I,JJ
56,confounding,I,NN
56,factors,I,NNS
56,.,O,.
57,Health,B,NNP
57,workers,I,NNS
57,and,O,CC
57,business,B,NN
57,people,I,NNS
57,became,O,VBD
57,increasingly,B,RB
57,anxious,B,JJ
57,",",O,","
57,but,O,CC
57,other,B,JJ
57,professionals,I,NNS
57,became,O,VBD
57,less,B,RBR
57,anxious,B,JJ
57,.,O,.
58,Currently,B,RB
58,",",O,","
58,COVID-19,B,NNP
58,has,O,VBZ
58,caused,B,VBN
58,global,B,JJ
58,health,I,NN
58,concern,I,NN
58,.,O,.
59,Covid-19,B,JJ
59,disease,I,NN
59,is,O,VBZ
59,caused,B,VBN
59,by,O,IN
59,SARS,B,NNP
59,-,I,:
59,CoV-2,I,NN
59,",",O,","
59,a,O,DT
59,virus,O,NN
59,belonging,O,NN
59,to,O,TO
59,the,O,DT
59,coronavirus,O,NN
59,family,O,NN
59,.,O,.
60,Studies,B,NNS
60,have,O,VBP
60,shown,B,VBN
60,that,O,IN
60,coagulation,B,NN
60,dysfunction,I,NN
60,is,O,VBZ
60,a,O,DT
60,major,B,JJ
60,cause,B,NN
60,of,I,IN
60,death,B,NN
60,in,B,IN
60,patients,I,NNS
60,with,I,IN
60,severe,I,JJ
60,COVID-19,I,NNP
60,.,O,.
61,Before,B,IN
61,2003,I,CD
61,",",O,","
61,two,B,CD
61,human,I,JJ
61,CoVs,I,NNP
61,(,O,(
61,HCoVs,B,NNP
61,),O,)
61,were,O,VBD
61,known,B,VBN
61,to,O,TO
61,cause,B,VB
61,mild,B,JJ
61,illness,I,NN
61,",",O,","
61,such,O,JJ
61,as,O,IN
61,common,B,JJ
61,cold,I,NN
61,.,O,.
62,A,B,DT
62,coronavirus,I,NN
62,(,O,(
62,HCoV-19,B,NNP
62,),O,)
62,has,B,VBZ
62,caused,B,VBN
62,the,B,DT
62,novel,I,JJ
62,coronavirus,I,NN
62,disease,I,NN
62,(,I,(
62,COVID-19,I,NNP
62,),I,)
62,outbreak,I,NN
62,in,B,IN
62,Wuhan,I,NNP
62,",",I,","
62,China,I,NNP
62,.,O,.
63,The,B,DT
63,mutations,I,NNS
63,might,B,MD
63,affect,B,VB
63,the,B,DT
63,severity,I,NN
63,and,I,CC
63,spread,I,NN
63,of,I,IN
63,the,I,DT
63,SARS,I,NNP
63,-,I,:
63,CoV-2,I,NN
64,Movement,B,JJ
64,restriction,I,NN
64,greatly,B,RB
64,reduced,B,VBD
64,the,B,DT
64,number,I,NN
64,of,I,IN
64,infections,I,NNS
64,from,B,IN
64,5,I,CD
64,February,I,NNP
64,onwards,I,NNS
64,.,O,.
65,Thus,O,RB
65,",",O,","
65,our,B,PRP$
65,results,I,NNS
65,suggest,B,VBP
65,that,O,IN
65,these,B,DT
65,drugs,I,NNS
65,could,B,MD
65,act,B,VB
65,against,I,IN
65,SARS,B,NNP
65,-,I,:
65,CoV-2,I,JJ
65,by,O,IN
65,altering,B,VBG
65,the,B,DT
65,folding,I,VBG
65,pathway,I,NN
65,of,I,IN
65,its,I,PRP$
65,receptor,I,NN
65,ACE2,I,NNP
66,Overall,O,JJ
66,",",O,","
66,our,B,PRP$
66,results,I,NNS
66,demonstrate,B,VB
66,the,O,DT
66,potential,B,JJ
66,efficacy,B,NN
66,of,O,IN
66,human,B,JJ
66,Type,I,NNP
66,I,I,PRP
66,IFN,I,NNP
66,in,O,IN
66,suppressing,B,VBG
66,SARS,B,NNP
66,-,I,:
66,CoV-2,I,JJ
66,infection,I,NN
67,With,O,IN
67,a,O,DT
67,modest,B,JJ
67,25,B,CD
67,%,I,NN
67,reduction,B,NN
67,in,I,IN
67,COVID-19,B,NNP
67,transmissibility,I,NN
67,via,B,IN
67,community,I,NN
67,-,I,:
67,level,I,NN
67,interventions,I,NNS
67,",",O,","
67,the,B,DT
67,epidemic,I,JJ
67,progression,I,NN
67,could,B,MD
67,be,O,VB
67,delayed,B,VBN
67,by,O,IN
67,up,B,IN
67,to,I,TO
67,34,I,CD
67,days,I,NNS
67,.,O,.
68,The,B,DT
68,genomic,I,JJ
68,signature,I,NN
68,analysis,I,NN
68,demonstrates,B,VBZ
68,that,O,IN
68,a,O,DT
68,strong,B,JJ
68,association,B,NN
68,between,O,IN
68,the,B,DT
68,time,I,NN
68,of,I,IN
68,sample,I,JJ
68,collection,I,NN
68,",",O,","
68,location,B,NN
68,of,I,IN
68,sample,I,NN
68,and,O,CC
68,accumulation,B,NN
68,of,I,IN
68,genetic,I,JJ
68,diversity,I,NN
68,.,O,.
69,Levels,B,NNS
69,of,I,IN
69,social,I,JJ
69,support,I,NN
69,for,B,IN
69,medical,I,JJ
69,staff,I,NN
69,were,O,VBD
69,significantly,B,RB
69,associated,B,VBN
69,with,I,IN
69,self,B,PRP
69,-,I,:
69,efficacy,I,NN
69,and,O,CC
69,sleep,B,JJ
69,quality,I,NN
69,and,O,CC
69,negatively,B,RB
69,associated,B,VBN
69,with,I,IN
69,the,B,DT
69,degree,I,NN
69,of,I,IN
69,anxiety,I,NN
69,and,O,CC
69,stress,B,NN
69,.,O,.
70,SEM,B,NN
70,showed,B,VBD
70,that,O,IN
70,medical,B,JJ
70,staff,I,NN
70,in,B,IN
70,China,I,NNP
70,who,B,WP
70,were,I,VBD
70,treating,I,VBG
70,patients,I,NNS
70,with,I,IN
70,COVID-19,I,NNP
70,infection,I,NN
70,during,B,IN
70,January,I,NNP
70,and,I,CC
70,February,I,NNP
70,2020,I,CD
70,had,O,VBD
70,levels,B,NNS
70,of,I,IN
70,anxiety,I,NN
70,",",O,","
70,stress,B,NN
70,",",O,","
70,and,O,CC
70,self,B,PRP
70,-,I,:
70,efficacy,I,NN
70,that,O,WDT
70,were,O,VBD
70,dependent,B,JJ
70,on,I,IN
70,sleep,B,JJ
70,quality,I,NN
70,and,O,CC
70,social,B,JJ
70,support,I,NN
71,There,O,EX
71,was,O,VBD
71,no,B,DT
71,statistically,B,RB
71,significant,I,JJ
71,difference,B,NN
71,between,O,IN
71,the,B,DT
71,smoking,I,NN
71,rates,I,NNS
71,of,O,IN
71,survivors,B,NNS
71,and,O,CC
71,non,B,JJ
71,-,I,:
71,survivors,I,NNS
71,(,O,(
71,p=0.21,O,NN
71,),O,)
71,with,B,IN
71,regard,I,NN
71,to,I,TO
71,mortality,I,NN
71,from,I,IN
71,COVID-19,I,NNP
71,.,O,.
72,Preliminary,B,JJ
72,evidence,I,NN
72,that,O,IN
72,higher,B,JJR
72,temperatures,B,NNS
72,are,O,VBP
72,associated,B,VBN
72,with,I,IN
72,lower,B,JJR
72,incidence,B,NN
72,of,I,IN
72,COVID-19,I,NNP
72,",",O,","
72,for,B,IN
72,cases,I,NNS
72,reported,I,VBN
72,globally,I,RB
72,up,I,IN
72,to,I,TO
72,29th,I,CD
72,February,I,NNP
72,2020,I,CD
73,Using,O,VBG
73,global,B,JJ
73,line,I,NN
73,-,I,:
73,list,I,NN
73,data,I,NNS
73,on,I,IN
73,COVID-19,I,NNP
73,cases,I,NNS
73,reported,I,VBD
73,until,I,IN
73,29th,I,CD
73,February,I,NNP
73,2020,I,CD
73,and,O,CC
73,global,B,JJ
73,gridded,I,JJ
73,temperature,I,NN
73,data,I,NNS
73,",",O,","
73,and,O,CC
73,after,B,IN
73,adjusting,I,VBG
73,for,I,IN
73,surveillance,I,NN
73,capacity,I,NN
73,and,I,CC
73,time,I,NN
73,since,I,IN
73,first,I,RB
73,imported,I,VBN
73,case,I,NN
73,",",O,","
73,higher,B,JJR
73,average,B,JJ
73,temperature,I,NN
73,was,O,VBD
73,strongly,B,RB
73,associated,B,VBN
73,with,I,IN
73,lower,B,JJR
73,COVID-19,B,NNP
73,incidence,I,NN
73,for,B,IN
73,temperatures,I,NNS
73,of,I,IN
73,1,I,CD
73,°,I,JJ
73,C,I,NNP
73,and,I,CC
73,higher,I,JJR
73,.,O,.
74,Preventive,B,JJ
74,measures,I,NNS
74,such,O,JJ
74,as,O,IN
74,masks,B,NNS
74,",",O,","
74,hand,B,NN
74,hygiene,I,NN
74,practices,I,NNS
74,",",O,","
74,avoidance,B,NN
74,of,I,IN
74,public,I,JJ
74,contact,I,NN
74,",",O,","
74,case,B,NN
74,detection,I,NN
74,",",O,","
74,contact,B,NN
74,tracing,I,NN
74,",",O,","
74,and,O,CC
74,quarantines,B,NNS
74,have,O,VBP
74,been,O,VBN
74,discussed,B,VBN
74,as,I,IN
74,ways,I,NNS
74,to,O,TO
74,reduce,B,VB
74,transmission,B,NN
74,.,O,.
75,Patients,B,NNS
75,with,I,IN
75,digestive,I,JJ
75,symptoms,I,NNS
75,had,O,VBD
75,higher,B,JJR
75,mean,B,JJ
75,liver,I,NN
75,enzyme,I,NN
75,levels,I,NNS
75,",",O,","
75,lower,B,JJR
75,monocyte,B,NN
75,count,I,NN
75,",",O,","
75,longer,B,JJR
75,prothrombin,B,JJ
75,time,I,NN
75,",",O,","
75,and,O,CC
75,received,B,VBD
75,more,B,RBR
75,antimicrobial,I,JJ
75,treatment,I,NN
75,than,O,IN
75,those,B,DT
75,without,I,IN
75,digestive,I,JJ
75,symptoms,I,NNS
75,.,O,.
76,Our,B,PRP$
76,prognosis,I,NN
76,suggests,B,VBZ
76,that,O,IN
76,in,B,IN
76,the,I,DT
76,absence,I,NN
76,of,I,IN
76,disease,I,NN
76,control,I,NN
76,interventions,I,NNS
76,and,I,CC
76,traffic,I,NN
76,restrictions,I,NNS
76,",",O,","
76,the,B,DT
76,nation,I,NN
76,-,I,:
76,wide,I,JJ
76,infected,I,JJ
76,fraction,I,NN
76,could,B,MD
76,reach,B,VB
76,~7,B,CD
76,%,I,NN
76,when,B,WRB
76,the,I,DT
76,epidemic,I,JJ
76,hits,I,VBZ
76,its,I,PRP$
76,peak,I,NN
76,by,I,IN
76,early,I,JJ
76,June,I,NNP
76,.,O,.
77,Based,O,VBN
77,on,O,IN
77,our,B,PRP$
77,model,I,NN
77,predictions,I,NNS
77,for,I,IN
77,the,I,DT
77,March,I,NNP
77,14,I,CD
77,-,I,:
77,16,I,CD
77,timeframe,I,NN
77,",",O,","
77,the,B,DT
77,national,I,JJ
77,epidemic,I,JJ
77,peak,I,NN
77,could,B,MD
77,be,O,VB
77,expected,B,VBN
77,to,O,TO
77,arrive,B,VB
77,by,B,IN
77,early,I,JJ
77,June,I,NNP
77,",",O,","
77,corresponding,B,VBG
77,to,I,TO
77,a,B,DT
77,daily,I,JJ
77,active,I,JJ
77,count,I,NN
77,of,I,IN
77,≈,I,$
77,7,I,CD
77,%,I,NN
77,of,B,IN
77,the,I,DT
77,US,I,NNP
77,population,I,NN
77,",",O,","
77,if,B,IN
77,no,I,DT
77,containment,I,NN
77,plans,I,NNS
77,are,I,VBP
77,implemented,I,VBN
77,.,O,.
78,The,B,DT
78,basic,I,JJ
78,reproduction,I,NN
78,number,I,NN
78,(,O,(
78,R0,B,NNP
78,),O,)
78,",",O,","
78,which,O,WDT
78,defines,B,VBZ
78,the,B,DT
78,mean,I,JJ
78,number,I,NN
78,of,I,IN
78,secondary,I,JJ
78,cases,I,NNS
78,generated,I,VBN
78,by,I,IN
78,one,I,CD
78,primary,I,JJ
78,case,I,NN
78,when,B,WRB
78,the,I,DT
78,population,I,NN
78,is,I,VBZ
78,largely,I,RB
78,susceptible,I,JJ
78,to,I,TO
78,infection,I,NN
78,",",O,","
78,determines,B,VBZ
78,the,B,DT
78,overall,I,JJ
78,number,I,NN
78,of,I,IN
78,people,I,NNS
78,who,I,WP
78,are,I,VBP
78,likely,I,JJ
78,to,I,TO
78,be,I,VB
78,infected,I,VBN
78,",",O,","
78,or,O,CC
78,more,O,RBR
78,precisely,O,RB
78,the,B,DT
78,area,I,NN
78,under,I,IN
78,the,I,DT
78,epidemic,I,JJ
78,curve,I,NN
78,.,O,.
79,Guidelines,B,NNS
79,developed,I,VBN
79,by,I,IN
79,experts,I,NNS
79,can,O,MD
79,improve,B,VB
79,the,B,DT
79,treatment,I,NN
79,of,I,IN
79,COVID-19,I,NNP
79,.,O,.
80,Second,O,JJ
80,",",O,","
80,we,O,PRP
80,demonstrate,B,VBP
80,how,O,WRB
80,simulation,B,NN
80,-,I,:
80,based,I,VBN
80,methodology,I,NN
80,can,O,MD
80,be,O,VB
80,used,O,VBN
80,to,O,TO
80,examine,B,VB
80,and,O,CC
80,predict,B,VB
80,the,O,DT
80,impacts,B,NNS
80,of,O,IN
80,epidemic,B,JJ
80,outbreaks,I,NNS
80,on,O,IN
80,the,B,DT
80,SC,I,NNP
80,performance,I,NN
80,using,B,VBG
80,the,I,DT
80,example,I,NN
80,of,I,IN
80,coronavirus,I,NN
80,COVID-19,I,NNP
80,and,O,CC
80,anyLogistix,B,JJ
80,simulation,I,NN
80,and,I,CC
80,optimization,I,NN
80,software,I,NN
80,.,O,.
81,What,B,WP
81,has,I,VBZ
81,happened,I,VBN
81,in,I,IN
81,China,I,NNP
81,shows,B,NNS
81,that,O,WDT
81,quarantine,B,VBP
81,",",O,","
81,social,B,JJ
81,distancing,I,NN
81,",",O,","
81,and,O,CC
81,isolation,B,NN
81,of,I,IN
81,infected,I,JJ
81,populations,I,NNS
81,can,O,MD
81,contain,B,VB
81,the,B,DT
81,epidemic.1,I,NN
82,One,B,CD
82,study,I,NN
82,(,O,(
82,"preprint),1",O,IN
82,using,O,VBG
82,single,O,JJ
82,-,O,:
82,cell,O,NN
82,sequencing,O,NN
82,",",O,","
82,found,B,VBD
82,that,O,IN
82,expression,B,NN
82,of,I,IN
82,ACE2,I,NNP
82,was,O,VBD
82,more,B,RBR
82,predominant,I,JJ
82,in,O,IN
82,Asian,B,JJ
82,men,I,NNS
82,",",O,","
82,which,O,WDT
82,might,B,MD
82,be,O,VB
82,the,O,DT
82,reason,B,NN
82,for,I,IN
82,the,O,DT
82,higher,B,JJR
82,prevalence,B,NN
82,of,I,IN
82,COVID-19,I,NNP
82,in,O,IN
82,this,B,DT
82,subgroup,I,NN
82,of,I,IN
82,patients,I,NNS
82,than,O,IN
82,in,O,IN
82,women,B,NNS
82,and,O,CC
82,patients,B,NNS
82,of,I,IN
82,other,I,JJ
82,ethnicities,I,NNS
82,.,O,.
83,Unfortunately,B,RB
83,",",O,","
83,emergence,B,NN
83,of,I,IN
83,SARS,I,NNP
83,-,I,:
83,CoV-2,I,NN
83,has,O,VBZ
83,led,B,VBN
83,to,I,TO
83,numerous,B,JJ
83,reports,I,NNS
83,of,O,IN
83,Asians,B,NNPS
83,being,I,VBG
83,subjected,I,VBN
83,to,I,TO
83,racist,I,VB
83,behavior,I,NN
83,and,O,CC
83,hate,B,NN
83,crimes,I,NNS
83,across,B,IN
83,the,I,DT
83,world,I,NN
83,.,O,.
84,Further,B,JJ
84,calculations,I,NNS
84,",",O,","
84,again,O,RB
84,based,O,VBN
84,on,O,IN
84,travel,B,NN
84,volumes,I,NNS
84,",",O,","
84,suggested,B,VBD
84,that,O,IN
84,some,B,DT
84,countries,I,NNS
84,would,B,MD
84,be,O,VB
84,expected,B,VBN
84,to,O,TO
84,have,O,VB
84,many,B,JJ
84,more,B,JJR
84,travel,B,JJ
84,-,I,:
84,related,I,JJ
84,cases,I,NNS
84,than,O,IN
84,had,B,VBD
84,been,I,VBN
84,"notified,4",I,RB
84,drawing,O,VBG
84,attention,O,NN
84,to,O,TO
84,the,O,DT
84,possibility,O,NN
84,of,O,IN
84,undetected,B,JJ
84,cases,I,NNS
84,and,O,CC
84,community,B,NN
84,transmission,I,NN
84,in,B,IN
84,several,I,JJ
84,countries,I,NNS
84,.,O,.
85,Conclusions,O,NNS
85,Six,B,NNP
85,-,I,:
85,week,I,NN
85,respiratory,I,NN
85,rehabilitation,I,NN
85,can,O,MD
85,improve,B,VB
85,respiratory,B,NN
85,function,I,NN
85,",",O,","
85,QoL,B,NNP
85,and,O,CC
85,anxiety,B,NN
85,of,B,IN
85,elderly,I,JJ
85,patients,I,NNS
85,with,I,IN
85,COVID-19,I,NNP
85,",",O,","
85,but,O,CC
85,it,O,PRP
85,has,O,VBZ
85,little,B,JJ
85,significant,I,JJ
85,improvement,B,NN
85,on,I,IN
85,depression,B,NN
85,in,B,IN
85,the,I,DT
85,elderly,I,JJ
85,.,O,.
86,Although,O,IN
86,applicable,O,JJ
86,to,O,TO
86,disease,O,VB
86,modelling,O,VBG
86,in,O,IN
86,general,O,JJ
86,",",O,","
86,our,B,PRP$
86,results,I,NNS
86,emphasize,B,VB
86,how,O,WRB
86,network,B,NN
86,science,I,NN
86,can,O,MD
86,improve,B,VB
86,the,B,DT
86,predictive,I,JJ
86,power,I,NN
86,of,I,IN
86,current,I,JJ
86,COVID-19,I,NNP
86,epidemiological,I,NN
86,models,I,NNS
87,Some,B,DT
87,statistical,I,JJ
87,studies,I,NNS
87,have,O,VBP
87,shown,B,VBN
87,that,O,IN
87,",",O,","
87,on,B,IN
87,average,I,NN
87,",",O,","
87,one,B,CD
87,infected,I,VBN
87,patient,I,NN
87,may,B,MD
87,lead,B,VB
87,to,I,TO
87,a,B,DT
87,subsequent,I,JJ
87,5.7,I,CD
87,confirmed,I,JJ
87,cases,I,NNS
87,.,O,.
88,The,B,DT
88,costs,I,NNS
88,of,I,IN
88,the,I,DT
88,epidemic,I,NNS
88,are,O,VBP
88,not,B,RB
88,limited,B,VBN
88,to,I,TO
88,medical,B,JJ
88,aspects,I,NNS
88,",",O,","
88,as,O,IN
88,the,B,DT
88,virus,I,NN
88,has,O,VBZ
88,led,B,VBN
88,to,I,TO
88,significant,B,JJ
88,sociological,B,JJ
88,",",O,","
88,psychological,B,JJ
88,and,O,CC
88,economic,B,JJ
88,effects,I,NNS
88,globally,B,RB
88,.,O,.
89,The,B,DT
89,COVID-19,I,NNP
89,pandemic,I,NN
89,has,O,VBZ
89,led,B,VBN
89,to,I,TO
89,the,B,DT
89,cancellation,I,NN
89,of,I,IN
89,many,I,JJ
89,conferences,I,NNS
89,",",O,","
89,forcing,O,VBG
89,the,O,DT
89,scientific,O,JJ
89,community,O,NN
89,to,O,TO
89,explore,O,VB
89,online,O,JJ
89,alternatives,O,NNS
89,.,O,.
90,The,B,DT
90,outbreak,I,NN
90,has,O,VBZ
90,led,B,VBN
90,to,I,TO
90,severe,B,VB
90,impacts,B,NNS
90,on,O,IN
90,social,B,JJ
90,health,I,NN
90,and,O,CC
90,the,B,DT
90,economy,I,NN
90,at,B,IN
90,various,I,JJ
90,levels,I,NNS
90,.,O,.
91,As,B,IN
91,of,I,IN
91,March,I,NNP
91,24th,I,CD
91,",",I,","
91,2020,I,CD
91,",",O,","
91,the,B,DT
91,virus,I,NN
91,has,O,VBZ
91,caused,B,VBN
91,a,B,DT
91,casualty,I,NN
91,of,I,IN
91,over,I,IN
91,"16,600",I,CD
91,people,I,NNS
91,worldwide,I,RB
91,.,O,.
92,A,O,DT
92,total,O,NN
92,of,O,IN
92,six,B,CD
92,species,I,NNS
92,have,O,VBP
92,been,O,VBN
92,identified,B,VBN
92,to,O,TO
92,cause,B,VB
92,disease,B,NN
92,in,B,IN
92,humans,I,NNS
92,.,O,.
93,induced,B,JJ
93,activation,B,NN
93,of,I,IN
93,apoptosis,I,NN
93,and,O,CC
93,P53,B,NNP
93,signalling,I,VBG
93,pathway,I,RB
93,in,I,IN
93,lymphocytes,I,NNS
93,may,B,MD
93,be,O,VB
93,the,O,DT
93,cause,B,NN
93,of,I,IN
93,patients,B,NNS
93,’,I,JJ
93,lymphopenia,I,NN
93,.,O,.
94,This,B,DT
94,could,B,MD
94,be,O,VB
94,the,O,DT
94,cause,B,NN
94,of,I,IN
94,the,B,DT
94,rapid,I,JJ
94,viral,I,JJ
94,spread,I,NN
94,of,I,IN
94,SARS,I,NNP
94,-,I,:
94,CoV-2,I,NN
94,in,B,IN
94,humans,I,NNS
94,.,O,.
95,SARS‐CoV‐2,B,NNP
95,caused,B,VBD
95,more,B,RBR
95,severe,B,JJ
95,interstitial,I,JJ
95,pneumonia,I,NN
95,in,O,IN
95,old,B,JJ
95,monkeys,I,NNS
95,than,O,IN
95,that,O,DT
95,in,O,IN
95,young,B,JJ
95,monkeys,I,NNS
95,.,O,.
96,In,B,IN
96,humans,I,NNS
96,",",O,","
96,CoVs,B,NNP
96,mostly,B,RB
96,cause,B,VBP
96,respiratory,B,NN
96,and,O,CC
96,gastrointestinal,B,JJ
96,symptoms,I,NNS
96,.,O,.
97,However,O,RB
97,",",O,","
97,CoVs,B,NNP
97,have,O,VBP
97,been,O,VBN
97,known,B,VBN
97,to,O,TO
97,cause,B,VB
97,various,B,JJ
97,ocular,I,JJ
97,infections,I,NNS
97,in,B,IN
97,animals,I,NNS
97,.,O,.
98,This,B,DT
98,study,I,NN
98,aimed,O,VBD
98,to,O,TO
98,determine,B,VB
98,whether,B,IN
98,the,B,DT
98,temperature,I,NN
98,is,O,VBZ
98,an,O,DT
98,essential,B,JJ
98,factor,B,NN
98,in,I,IN
98,the,B,DT
98,infection,I,NN
98,caused,B,VBN
98,by,O,IN
98,this,B,DT
98,novel,I,JJ
98,coronavirus,I,NN
98,.,O,.
99,Considered,O,VBN
99,a,O,DT
99,relative,O,NN
99,of,O,IN
99,severe,B,JJ
99,acute,I,JJ
99,respiratory,I,NN
99,syndrome,I,NN
99,(,O,(
99,SARS,B,NNP
99,),O,)
99,and,O,CC
99,Middle,B,NNP
99,East,I,NNP
99,respiratory,I,NN
99,syndrome,I,NN
99,(,O,(
99,MERS,B,NNP
99,),O,)
99,",",O,","
99,COVID-19,B,NNP
99,is,O,VBZ
99,caused,B,VBN
99,by,O,IN
99,a,B,DT
99,betacoronavirus,I,NN
99,named,I,VBN
99,SARS,I,NNP
99,-,I,:
99,CoV-2,I,NN
100,COVID-19,B,NNP
100,is,O,VBZ
100,caused,B,VBN
100,by,O,IN
100,severe,B,JJ
100,acute,I,JJ
100,respiratory,I,NN
100,syndrome,I,NN
100,coronavirus,I,NN
100,2,I,CD
100,(,O,(
100,SARS,B,NNP
100,-,I,:
100,CoV-2,I,NN
100,),O,)
100,.,O,.
101,Coronavirus,B,NNP
101,disease,I,NN
101,of,I,IN
101,2019,I,CD
101,(,O,(
101,COVID-19,B,NNP
101,),O,)
101,is,O,VBZ
101,a,O,DT
101,cause,B,NN
101,of,I,IN
101,significant,B,JJ
101,morbidity,B,NN
101,and,O,CC
101,mortality,B,NN
101,worldwide,B,NN
101,.,O,.
102,Among,O,IN
102,other,O,JJ
102,insights,O,NNS
102,",",O,","
102,the,B,DT
102,results,I,NNS
102,suggest,B,VBP
102,installing,B,VBG
102,temporary,I,JJ
102,incinerators,I,NNS
102,may,B,MD
102,be,O,VB
102,an,O,DT
102,effective,B,JJ
102,solution,O,NN
102,for,O,IN
102,managing,B,VBG
102,the,O,DT
102,tremendous,B,JJ
102,increase,B,NN
102,of,O,IN
102,medical,B,JJ
102,waste,I,NN
102,during,B,IN
102,the,I,DT
102,COVID-19,I,NNP
102,outbreak,I,NN
102,in,B,IN
102,Wuhan,I,NNP
102,",",O,","
102,but,O,CC
102,the,B,DT
102,location,I,NN
102,selection,I,NN
102,of,I,IN
102,these,I,DT
102,temporary,I,JJ
102,incinerators,I,NNS
102,is,O,VBZ
102,of,O,IN
102,significant,B,JJ
102,importance,O,NN
102,.,O,.
103,This,B,DT
103,study,I,NN
103,aimed,O,VBD
103,to,O,TO
103,provide,B,VB
103,preliminary,I,JJ
103,data,I,NNS
103,on,I,IN
103,whether,B,IN
103,there,O,EX
103,may,B,MD
103,be,O,VB
103,seasonal,B,JJ
103,variation,B,NN
103,in,I,IN
103,COVID-19,B,NNP
103,incidence,I,NN
103,",",O,","
103,in,B,IN
103,sub,I,JJ
103,-,I,:
103,national,I,JJ
103,regions,I,NNS
103,that,O,WDT
103,have,O,VBP
103,reported,B,VBN
103,at,I,IN
103,least,I,JJS
103,one,I,CD
103,confirmed,I,VBD
103,COVID-19,I,NNP
103,case,I,NN
103,.,O,.
104,While,O,IN
104,human,B,JJ
104,strains,I,NNS
104,of,I,IN
104,Coronavirus,I,NNP
104,are,O,VBP
104,associated,B,VBN
104,with,I,IN
104,about,B,RB
104,15,I,CD
104,%,I,NN
104,of,O,IN
104,cases,B,NNS
104,of,I,IN
104,the,I,DT
104,common,I,JJ
104,cold,I,NN
104,",",O,","
104,the,B,DT
104,SARS,I,NNP
104,-,I,:
104,CoV-2,I,NN
104,may,B,MD
104,present,B,VB
104,with,I,IN
104,varying,B,VBG
104,degrees,I,NNS
104,of,I,IN
104,severity,I,NN
104,",",O,","
104,from,O,IN
104,flu,B,JJ
104,-,I,:
104,like,I,IN
104,symptoms,I,NNS
104,to,O,TO
104,death,B,NN
104,.,O,.
105,Nonetheless,O,RB
105,",",O,","
105,it,O,PRP
105,has,O,VBZ
105,been,O,VBN
105,consistently,B,RB
105,shown,I,VBN
105,that,O,IN
105,the,B,DT
105,presence,I,NN
105,of,I,IN
105,pre,I,JJ
105,-,I,:
105,existing,I,VBG
105,CV,I,NNP
105,disease,I,NN
105,and/or,O,NN
105,development,B,NN
105,of,I,IN
105,acute,I,JJ
105,cardiac,I,JJ
105,injury,I,NN
105,are,O,VBP
105,associated,B,VBN
105,with,I,IN
105,significantly,B,RB
105,worse,B,JJR
105,outcome,B,NN
105,in,B,IN
105,these,I,DT
105,patients,I,NNS
105,.,O,.
106,The,B,DT
106,number,I,NN
106,of,I,IN
106,likes,I,NNS
106,and,I,CC
106,retweets,I,NNS
106,per,I,IN
106,tweet,I,NN
106,was,O,VBD
106,not,B,RB
106,associated,B,VBN
106,with,I,IN
106,a,O,DT
106,difference,B,NN
106,in,I,IN
106,either,O,CC
106,false,B,JJ
106,or,O,CC
106,unverifiable,B,JJ
106,content,I,NN
106,.,O,.
107,While,O,IN
107,these,B,DT
107,quarantine,I,JJ
107,measures,I,NNS
107,are,O,VBP
107,necessary,O,JJ
107,and,O,CC
107,have,O,VBP
107,prevented,B,VBN
107,a,B,DT
107,historical,I,JJ
107,disaster,I,NN
107,along,I,IN
107,the,I,DT
107,lines,I,NNS
107,of,I,IN
107,the,I,DT
107,Spanish,I,JJ
107,flu,I,NN
107,",",O,","
107,earlier,B,JJR
107,recognition,B,NN
107,and,O,CC
107,earlier,B,JJR
107,implementation,B,NN
107,of,I,IN
107,quarantine,I,JJ
107,measures,I,NNS
107,may,B,MD
107,have,O,VB
107,been,O,VBN
107,even,O,RB
107,more,B,RBR
107,effective,I,JJ
107,.,O,.
108,Plotting,O,VBG
108,mortality,B,NN
108,against,O,IN
108,the,B,DT
108,incidence,I,NN
108,of,I,IN
108,COVID-19,I,NNP
108,(,O,(
108,cumulative,O,JJ
108,number,O,NN
108,of,O,IN
108,confirmed,O,JJ
108,cases,O,NNS
108,since,O,IN
108,the,O,DT
108,start,O,NN
108,of,O,IN
108,the,O,DT
108,outbreak,O,NN
108,",",O,","
108,per,O,IN
108,10,O,CD
108,000,O,CD
108,population,O,NN
108,),O,)
108,showed,B,VBD
108,a,O,DT
108,significant,B,JJ
108,positive,B,JJ
108,correlation,B,NN
108,(,O,(
108,figure,O,JJ
108,C,O,NNP
108,),O,)
108,",",O,","
108,suggesting,B,VBG
108,that,O,IN
108,mortality,B,NN
108,is,O,VBZ
108,correlated,B,VBN
108,with,I,IN
108,health,B,NN
108,-,I,:
108,care,I,NN
108,burden,I,NN
108,.,O,.
109,In,O,IN
109,conclusion,O,NN
109,",",O,","
109,with,O,IN
109,the,B,DT
109,limited,I,JJ
109,available,I,JJ
109,data,I,NNS
109,",",O,","
109,smoking,B,NN
109,is,O,VBZ
109,most,B,RBS
109,likely,I,JJ
109,associated,B,VBN
109,with,I,IN
109,the,B,DT
109,negative,I,JJ
109,progression,I,NN
109,and,I,CC
109,adverse,I,JJ
109,outcomes,I,NNS
109,of,I,IN
109,COVID-19,I,NNP
109,.,O,.
110,Average,B,JJ
110,temperature,I,NN
110,(,O,(
110,as,O,IN
110,a,O,DT
110,linear,O,JJ
110,and,O,CC
110,quadratic,O,JJ
110,term,O,NN
110,combination,O,NN
110,),O,)
110,was,O,VBD
110,strongly,B,RB
110,associated,B,VBN
110,with,I,IN
110,count,B,NN
110,of,I,IN
110,local,I,JJ
110,COVID-19,I,NNP
110,cases,I,NNS
110,(,O,(
110,likelihood,B,NN
110,ratio,I,NN
110,test,I,NN
110,=,O,NN
110,19.4,O,CD
110,",",O,","
110,df,O,NN
110,=,O,VBD
110,2,O,CD
110,",",O,","
110,p=0.00006,O,NN
110,),O,)
110,.,O,.
111,This,B,DT
111,sex,I,NN
111,predisposition,I,NN
111,might,B,MD
111,be,O,VB
111,associated,B,VBN
111,with,I,IN
111,the,O,DT
111,much,B,RB
111,higher,B,JJR
111,smoking,B,VBG
111,rate,I,NN
111,in,O,IN
111,men,B,NNS
111,than,O,IN
111,in,O,IN
111,women,B,NNS
111,in,B,IN
111,China,I,NNP
111,(,O,(
111,288,O,CD
111,million,O,CD
111,men,O,NNS
111,vs,O,$
111,12·6,O,CD
111,million,O,CD
111,women,O,NNS
111,were,O,VBD
111,smokers,O,NNS
111,in,O,IN
111,2018,O,CD
111,),O,)
111,.,O,.
112,The,B,DT
112,COVID-19,I,NNP
112,outbreak,I,NN
112,in,B,IN
112,Hubei,I,NNP
112,resulted,B,VBD
112,in,I,IN
112,increased,B,JJ
112,stress,B,NN
112,for,B,IN
112,medical,I,JJ
112,staff,I,NN
112,in,B,IN
112,adjacent,I,JJ
112,Hunan,I,NNP
112,province,I,NN
112,.,O,.
113,The,O,DT
113,reduced,B,JJ
113,probability,B,NN
113,of,I,IN
113,a,I,DT
113,major,I,JJ
113,epidemic,I,JJ
113,ranged,O,VBN
113,from,B,IN
113,7,I,CD
113,%,I,NN
113,to,I,TO
113,20,I,CD
113,%,I,NN
113,in,B,IN
113,Japan,I,NNP
113,",",O,","
113,which,O,WDT
113,resulted,B,VBD
113,in,I,IN
113,a,B,DT
113,median,I,JJ
113,time,I,NN
113,delay,I,NN
113,to,I,TO
113,a,I,DT
113,major,I,JJ
113,epidemic,I,NN
113,of,O,IN
113,two,B,CD
113,days,I,NNS
113,.,O,.
114,Lessons,B,NNS
114,learned,I,VBD
114,from,I,IN
114,SARS,I,NNP
114,resulted,B,VBD
114,in,I,IN
114,faster,B,JJ
114,determination,B,NN
114,of,I,IN
114,the,I,DT
114,nucleic,I,JJ
114,acid,I,NN
114,sequence,I,NN
114,and,O,CC
114,a,O,DT
114,more,B,RBR
114,robust,B,JJ
114,quarantine,I,NN
114,strategy,I,NN
114,.,O,.
115,We,O,PRP
115,summarize,B,VBP
115,the,B,DT
115,cardiovascular,I,JJ
115,risks,I,NNS
115,associated,B,VBN
115,with,I,IN
115,Covid-19,B,NNP
115,pandemic,I,NN
115,",",O,","
115,discussing,O,VBG
115,the,O,DT
115,risks,O,NNS
115,for,O,IN
115,both,O,DT
115,infected,B,JJ
115,and,O,CC
115,non,B,JJ
115,-,I,:
115,infected,I,JJ
115,patients,I,NNS
115,.,O,.
116,Studies,B,NNS
116,on,O,IN
116,the,B,DT
116,biology,I,NN
116,of,I,IN
116,viral,I,JJ
116,infection,I,NN
116,and,O,CC
116,clinical,B,JJ
116,management,I,NN
116,of,I,IN
116,the,I,DT
116,disease,I,NN
116,have,O,VBP
116,also,O,RB
116,been,O,VBN
116,published,O,VBN
116,",",O,","
116,some,O,DT
116,of,O,IN
116,which,O,WDT
116,have,O,VBP
116,demonstrated,B,VBN
116,that,O,IN
116,differences,B,NNS
116,in,I,IN
116,COVID-19,B,NNP
116,disease,I,NN
116,prevalence,I,NN
116,and,O,CC
116,severity,B,NN
116,are,O,VBP
116,associated,B,VBN
116,with,I,IN
116,sex,B,NN
116,",",O,","
116,and,O,CC
116,smoking,B,NN
116,is,O,VBZ
116,related,B,VBN
116,to,I,TO
116,higher,B,JJR
116,expression,B,NN
116,of,I,IN
116,ACE2,I,NNP
116,(,O,(
116,the,O,DT
116,receptor,O,NN
116,for,O,IN
116,severe,B,JJ
116,acute,I,JJ
116,respiratory,I,NN
116,syndrome,I,NN
116,coronavirus,I,NN
116,2,I,CD
116,[,O,NN
116,SARS,B,NNP
116,-,I,:
116,CoV-2,I,JJ
116,],O,NN
116,),O,)
116,",",O,","
116,so,O,RB
116,that,O,IN
116,might,O,MD
116,also,O,RB
116,be,O,VB
116,a,O,DT
116,factor,O,NN
116,.,O,.
117,The,B,DT
117,pulmonary,I,JJ
117,function,I,NN
117,and,O,CC
117,symptoms,B,NNS
117,of,I,IN
117,these,I,DT
117,seven,I,CD
117,patients,I,NNS
117,were,O,VBD
117,significantly,B,RB
117,improved,B,VBN
117,in,B,IN
117,2,I,CD
117,days,I,NNS
117,after,O,IN
117,MSC,B,NNP
117,transplantation,I,NN
117,.,O,.
118,far,B,RB
118,-,I,:
118,reaching,I,VBG
118,solutions,I,NNS
118,were,O,VBD
118,implemented,B,VBN
118,relatively,I,RB
118,early,I,JJ
118,to,O,TO
118,reduce,B,VB
118,the,B,DT
118,spread,I,NN
118,of,I,IN
118,infection,I,NN
118,.,O,.
119,As,B,IN
119,we,I,PRP
119,await,I,VBP
119,more,I,JJR
119,data,I,NNS
119,from,I,IN
119,treating,I,VBG
119,these,I,DT
119,patients,I,NNS
119,",",O,","
119,this,B,DT
119,strategy,I,NN
119,is,O,VBZ
119,likely,B,JJ
119,to,O,TO
119,help,O,VB
119,reduce,B,VB
119,potential,B,JJ
119,complications,I,NNS
119,.,O,.
120,the,B,DT
120,effect,I,NN
120,progressively,B,RB
120,increased,B,VBD
120,as,O,IN
120,the,B,DT
120,probability,I,NN
120,of,I,IN
120,infection,I,NN
120,increased,B,VBN
120,.,O,.
121,There,O,EX
121,were,O,VBD
121,more,B,JJR
121,case,B,NN
121,fatalities,I,NNS
121,among,O,IN
121,COVID-19,B,JJ
121,patients,I,NNS
121,without,I,IN
121,comorbidities,I,NNS
121,than,O,IN
121,in,O,IN
121,the,B,DT
121,reference,I,NN
121,cohort,I,NN
121,.,O,.
122,Even,O,RB
122,more,O,RBR
122,complex,O,JJ
122,is,O,VBZ
122,the,O,DT
122,situation,O,NN
122,of,O,IN
122,patients,O,NNS
122,in,O,IN
122,ICU,O,NNP
122,",",O,","
122,where,O,WRB
122,viral,B,JJ
122,spreading,I,NN
122,is,O,VBZ
122,facilitated,B,VBN
122,by,O,IN
122,endotracheal,B,JJ
122,tubes,I,NNS
122,and,O,CC
122,manoeuvres,B,NNS
122,performed,I,VBN
122,on,I,IN
122,the,I,DT
122,respiratory,I,NN
122,tract,I,NN
122,.,O,.
123,Staffing,B,VBG
123,along,I,RB
123,epidemiologic,I,JJ
123,considerations,I,NNS
123,may,B,MD
123,reduce,B,VB
123,HCW,B,NNP
123,shortage,I,NN
123,by,O,IN
123,leveling,B,VBG
123,the,B,DT
123,nadir,I,NN
123,of,I,IN
123,affected,I,JJ
123,workforce,I,NN
123,.,O,.
124,It,O,PRP
124,was,O,VBD
124,found,B,VBN
124,that,O,IN
124,the,B,DT
124,PM2.5,I,NNP
124,concentrations,I,NNS
124,showed,O,VBD
124,a,O,DT
124,high,B,JJ
124,reduction,B,NN
124,of,O,IN
124,up,B,IN
124,to,I,TO
124,58.4,I,CD
124,%,I,NN
124,during,B,IN
124,the,I,DT
124,MCO,I,NNP
124,.,O,.
125,In,O,IN
125,addition,O,NN
125,",",O,","
125,ACEI,B,NNP
125,or,O,CC
125,ARB,B,NNP
125,therapy,I,NN
125,increased,B,VBD
125,CD3,B,NNP
125,and,O,CC
125,CD8,B,NNP
125,T,I,NNP
125,cell,I,NN
125,counts,I,NNS
125,in,B,IN
125,peripheral,I,JJ
125,blood,I,NN
125,and,O,CC
125,decreased,B,VBD
125,the,B,DT
125,peak,I,JJ
125,viral,I,JJ
125,load,I,NN
125,compared,O,VBN
125,to,O,TO
125,other,B,JJ
125,antihypertensive,I,JJ
125,drugs,I,NNS
125,.,O,.
126,Respiratory,B,NNP
126,illness,I,NN
126,is,O,VBZ
126,the,O,DT
126,dominant,B,JJ
126,clinical,B,JJ
126,manifestation,B,NN
126,of,I,IN
126,COVID-19,B,NNP
126,.,O,.
127,This,B,DT
127,viral,I,JJ
127,epidemic,I,NN
127,in,B,IN
127,China,I,NNP
127,has,O,VBZ
127,led,B,VBN
127,to,I,TO
127,the,B,DT
127,deaths,I,NNS
127,of,I,IN
127,over,I,IN
127,1800,I,CD
127,people,I,NNS
127,",",O,","
127,mostly,B,RB
127,elderly,B,JJ
127,or,O,CC
127,those,B,DT
127,with,I,IN
127,an,I,DT
127,underlying,I,VBG
127,chronic,I,JJ
127,disease,I,NN
127,or,O,CC
127,immunosuppressed,B,JJ
127,state,I,NN
127,.,O,.
128,While,O,IN
128,in,B,IN
128,most,I,JJS
128,cases,I,NNS
128,",",O,","
128,mild,B,NN
128,symptoms,I,NNS
128,are,O,VBP
128,observed,B,VBN
128,",",O,","
128,in,B,IN
128,some,I,DT
128,cases,I,NNS
128,the,B,DT
128,infection,I,NN
128,leads,B,VBZ
128,to,I,TO
128,serious,B,JJ
128,pulmonary,I,JJ
128,disease,I,NN
128,.,O,.
129,This,B,DT
129,virus,I,NN
129,causes,B,VBZ
129,the,B,DT
129,coronavirus,I,NN
129,disease,I,NN
129,2019,I,CD
129,(,O,(
129,COVID-19,B,NNP
129,),O,)
129,.,O,.
130,Most,B,JJS
130,patients,B,NNS
130,with,I,IN
130,confirmed,I,JJ
130,or,I,CC
130,suspected,I,VBN
130,COVID,I,NNP
130,19,I,CD
130,presented,B,VBN
130,with,I,IN
130,fever,B,NN
130,and,O,CC
130,dry,B,JJ
130,cough,I,NN
130,and,O,CC
130,demonstrated,B,VBD
130,bilateral,B,JJ
130,multiple,I,JJ
130,mottling,I,NN
130,and,O,CC
130,ground,B,NN
130,-,I,:
130,glass,I,NN
130,opacity,I,NN
130,on,B,IN
130,chest,I,NN
130,computed,I,VBN
130,tomography,I,NN
130,scans,I,NNS
130,.,O,.
131,The,B,DT
131,relatively,I,RB
131,small,I,JJ
131,proportion,I,NN
131,of,I,IN
131,current,I,JJ
131,smokers,I,NNS
131,in,I,IN
131,each,I,DT
131,of,I,IN
131,these,I,DT
131,two,I,CD
131,studies,I,NNS
131,compared,O,VBN
131,with,O,IN
131,the,B,DT
131,proportion,I,NN
131,of,I,IN
131,male,I,JJ
131,smokers,I,NNS
131,in,I,IN
131,China,I,NNP
131,(,O,(
131,50·5,O,CD
131,%,O,NN
131,),O,)
131,are,O,VBP
131,unlikely,B,JJ
131,to,O,TO
131,be,O,VB
131,associated,B,VBN
131,with,I,IN
131,incidence,B,NN
131,or,I,CC
131,severity,I,NN
131,of,I,IN
131,COVID-19,I,NNP
131,.,O,.
132,The,B,DT
132,elderly,I,JJ
132,and,O,CC
132,people,B,NNS
132,with,I,IN
132,underlying,I,JJ
132,diseases,I,NNS
132,are,O,VBP
132,susceptible,B,JJ
132,to,I,TO
132,infection,B,NN
132,and,O,CC
132,prone,B,NN
132,to,I,TO
132,serious,B,JJ
132,outcomes,I,NNS
132,",",O,","
132,which,O,WDT
132,may,B,MD
132,be,O,VB
132,associated,B,VBN
132,with,I,IN
132,acute,B,JJ
132,respiratory,I,NN
132,distress,I,NN
132,syndrome,I,NN
132,(,O,(
132,ARDS,B,NNP
132,),O,)
132,and,O,CC
132,cytokine,B,JJ
132,storm,I,NN
132,.,O,.
133,differences,B,NNS
133,in,I,IN
133,COVID-19,B,NNP
133,disease,I,NN
133,prevalence,I,NN
133,and,O,CC
133,severity,B,NN
133,are,O,VBP
133,associated,B,VBN
133,with,I,IN
133,sex,B,NN
133,",",O,","
133,and,O,CC
133,smoking,B,NN
133,is,O,VBZ
133,related,B,VBN
133,to,I,TO
133,higher,B,JJR
133,expression,B,NN
133,of,I,IN
133,ACE2,I,NNP
133,.,O,.
134,A,B,DT
134,new,I,JJ
134,study,I,NN
134,published,O,VBN
134,by,O,IN
134,the,O,DT
134,journal,O,NN
134,Aging,O,NNP
134,&,O,CC
134,Disease,O,NNP
134,reported,B,VBD
134,that,O,IN
134,intravenous,B,JJ
134,administration,I,NN
134,of,I,IN
134,clinical,I,JJ
134,-,I,:
134,grade,I,NN
134,human,I,JJ
134,mesenchymal,I,JJ
134,stem,I,NN
134,cells,I,NNS
134,(,O,(
134,MSCs,B,NNP
134,),O,)
134,into,B,IN
134,patients,I,NNS
134,with,I,IN
134,coronavirus,B,JJ
134,disease,I,NN
134,2019,I,CD
134,(,I,(
134,COVID-19,B,NNP
134,),O,)
134,resulted,B,VBD
134,in,I,IN
134,improved,B,JJ
134,functional,B,JJ
134,outcomes,I,NNS
134,(,O,(
134,Leng,B,NNP
134,et,I,RB
134,al,I,RB
134,.,I,.
134,",",I,","
134,Aging,I,VBG
134,Dis,I,NNP
134,",",I,","
134,11:216,I,CD
134,-,I,:
134,228,I,CD
134,",",I,","
134,2020,I,CD
134,),O,)
134,.,O,.
